The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Vitamin D in Systemic Lupus Erythematosus: Modest Association With Disease Activity and the Urine Protein‐to‐Creatinine Ratio
Open accessAbstract
Objective: To investigate whether an increase in vitamin D levels in patients with systemic lupus erythematosus (SLE) was associated with improvement in disease activity. Methods: A total of 1,006 SLE patients were monitored over 128 weeks. SLE patients with low levels of 25‐hydroxyvitamin D (25[OH]D; <40 ng/ml) were given supplements of 50,000 units of vitamin D 2 weekly plus 200 units of calcium/vitamin D 3 twice daily. Longitudinal regression models were used to estimate the association between levels of 25(OH)D and various measures of disease activity. Results: The SLE patients had the following characteristics: 91% were female, their mean age was 49.6 years, and their ethnicity was 54% Caucasian, 37% African American, and 8% other. For those with levels of 25(OH)D <40 ng/ml, a 20‐unit increase in the 25(OH)D level was associated with a mean decrease of 0.22 (95% confidence interval [95% CI] −0.41, −0.02) (P = 0.032) in the Safety of Estrogens in Lupus Erythematosus National Assessment (SELENA) version of the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI). This corresponded to a 21% decrease in the odds of having a SELENA–SLEDAI ≥5 (95% CI 1, 37). The mean urine protein‐to‐creatinine ratio decreased by 2% (95% CI −0.03, −0.01) (P = 0.0001), corresponding to a 15% decrease in the odds of having a ratio >0.5 (95% CI 2, 27). Conclusion: We found that a 20‐ng/ml increase in the 25(OH)D level was associated with a 21% decrease in the odds of having a high disease activity score and a 15% decrease in the odds of having clinically important proteinuria. Although these associations were statistically significant, the clinical importance is relatively modest. There was no evidence of additional benefit of 25(OH)D beyond a level of 40 ng/ml.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Holick, M. F. (2007) · New England Journal of Medicine · doi:10.1056/nejmra070553 · Cited by 13,720
Bolland, M. J., Avenell, A., Baron, J. A., Grey, A., MacLennan, G. S., Gamble, G. D., & Reid, I. R. (2010) · BMJ · doi:10.1136/bmj.c3691 · Cited by 1,099
Bolland, M. J., Grey, A., Avenell, A., Gamble, G. D., & Reid, I. R. (2011) · BMJ · doi:10.1136/bmj.d2040 · Cited by 851
Cited by
Systemic lupus erythematosus: Diagnosis and clinical management
Fava, A., & Petri, M. (2019) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.11.001 · Cited by 754
Self-citationManagement strategies and future directions for systemic lupus erythematosus in adults
Durcan, L., O'Dwyer, T., & Petri, M. (2019) · The Lancet · doi:10.1016/s0140-6736(19)30237-5 · Cited by 648
Self-citationModulation of inflammatory and immune responses by vitamin D
Colotta, F., Jansson, B., & Bonelli, F. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.07.007 · Cited by 399
Murdaca, G., Tonacci, A., Negrini, S., Greco, M., Borro, M., Puppo, F., & Gangemi, S. (2019) · Autoimmunity Reviews · doi:10.1016/j.autrev.2019.102350 · Cited by 306
An Update on the Effects of Vitamin D on the Immune System and Autoimmune Diseases
Sîrbe, C., Rednic, S., Grama, A., & Pop, T. L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179784 · Cited by 269
Immunomodulators in SLE: Clinical evidence and immunologic actions
Durcan, L., & Petri, M. (2016) · Journal of Autoimmunity · doi:10.1016/j.jaut.2016.06.010 · Cited by 92
“T regs: Increased Petri et al., 2013 [74] Longitudinal Cohort 1006 SLE USA (37% African American) 50,000 iu weekly þ 400 iu calcium/vitamin D daily SLEDAI Physician global (0 e3) UPCR SLEDAI: Significant decrease.”
BackgroundInfluentialSelf-citation
Metadata
- Authors
- Petri, M., Bello, K. J., Fang, H., & Magder, L. S.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2013-07
- Volume
- 65
- Issue
- 7
- Pages
- 1865-1871
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W1775819922
- Cited by
- 158
- References
- 3
- FWCI
- 15.26
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.